FIELD: medicine, prophylaxis of sexually-transmitted diseases. SUBSTANCE: the suggested condom lubricant contains an antiviral preparation and pharmaceutically acceptable target additives. It additionally contains a stabilizer of biological, physicochemical properties and/or resistance to microbial contamination, immunomodulator and/or antimicrobial preparation. As an antiviral preparation it contains alpha, or beta, or gamma recombinant interferon at the amount of 1000-10000000 IU/g preparation. EFFECT: increased number of antiviral and antimicrobial condom lubricants. 16 cl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
CURATIVE AGENT | 2000 |
|
RU2187332C1 |
ANTIVIRAL, ANTIBACTERIAL AND ANTICANDIDOSIS AGENT | 2000 |
|
RU2187328C1 |
ANTIVIRAL AGENT | 2000 |
|
RU2187330C1 |
MEDICINAL PREPARATION | 2000 |
|
RU2187331C1 |
SUPPOSITORY | 2006 |
|
RU2322968C1 |
INTRANASAL AGENT | 2002 |
|
RU2220739C1 |
AGENT FOR TREATMENT OF ALLERGIC RHINITIS AND ALLERGIC CONJUNCTIVITIS | 2002 |
|
RU2220740C1 |
PHARMACEUTICAL COMPOSITION IN FORM OF CAPSULE POSSESSING ANTIVIRAL, ANTI-INFLAMMATORY, ANTIMICROBIAL AND IMMUNOMODULATORY ACTION | 2012 |
|
RU2482872C1 |
ANTIVIRAL MEDICATION - NASAL DROPS | 2010 |
|
RU2437676C1 |
ANTIVIRAL AGENT - EYE DROPS | 2012 |
|
RU2473363C1 |
Authors
Dates
2002-08-20—Published
2000-12-18—Filed